Medications & Supplements/Prescription Drugs

Furosemide Tablets Recalled for Presence of Foreign Substance

Agency Publication Date: January 21, 2026

Summary

Graviti Pharmaceuticals is recalling 4,212 bottles of Furosemide Tablets, USP 40 mg (a medication used to treat fluid retention and high blood pressure) after a foreign substance was found in the product. The affected bottles were manufactured for Rising Pharmaceuticals Inc. and distributed nationwide throughout the United States. Consumers should check their prescription bottles to see if they have the specific lot number FUB125042G with an expiration date of May 2027.

Risk

The presence of a foreign substance in medication can pose a risk of injury or adverse health effects if ingested. The manufacturer has initiated this voluntary recall to ensure patient safety and product quality.

What You Should Do

Check your medication bottle to see if it is Furosemide Tablets, USP 40 mg with NDC 64980-563-10.
Verify the lot number and expiration date on the label: check for Lot FUB125042G with an expiration date of 05/13/2027.
If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Furosemide Tablets, USP 40 mg (1,000 Tablets)by Rising Pharmaceuticals Inc.

Variants: 40 mg, Tablet

Lot Numbers:

FUB125042G (Exp. 05/13/2027)

NDC:

64980-563-10

Manufactured for Rising Pharmaceuticals Inc.; Manufactured by Graviti Pharmaceuticals Pvt. Ltd.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 98289

Status: Active

Manufacturer: Graviti Pharmaceuticals Private Limited

Sold By: Pharmacies

Manufactured In: India

Units Affected: 4212 bottles

Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

Check your medication bottle to see if it is Furosemide Tablets, USP 40 mg with NDC 64980-563-10.

Verify the lot number and expiration date on the label: check for Lot FUB125042G with an expiration date of 05/13/2027.

If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.